Skip to main content
. Author manuscript; available in PMC: 2014 Jul 18.
Published in final edited form as: AIDS Behav. 2013 Jan;17(1):1–4. doi: 10.1007/s10461-012-0321-z

Table 3.

Base-case and univariate sensitivity analysis results

Infections prevented Net program cost ($*1000) QALYs saved Cost per QALY saved (CER, $)
Base-case results 3191 297,947 24,922 11,955
T = $380,877 3191 214,483 24,922 8606
T = $271,108 3191 564,796 24,922 22,663
Q2 = 6.95 3191 297,947 26,582 11,209
Q2 = 5.87 3191 297,947 23,135 12,879
Q1 = 0.05a 3191 297,947 26,022 11,450
Q1 = 0.03b 3191 297,947 23,821 12,508
γ2 − γ3 = 0.0304c 3345 243,296 25,913 9389
γ2 − γ3 = 0.0276d 3037 352,598 23,932 14,733
a

Based on 5.5% improvement in quality-of-life 1 year after ART initiation.[14]

b

Based on 3.2% improvement in quality-of-life 1 year after ART initiation.[14]

c

Corresponds to 80% reduction, due to ART, in the likelihood of secondary transmission.

d

Corresponds to 74% reduction, due to ART, in the likelihood of secondary transmission.